For patients requiring hemofiltration for ARF, ICU’s require a versatile solution, one that is flexible enough to allow them to address constantly changing patient needs. Normocarb HF is a protocol-neutral solution that can be easily adjusted to respond to immediate needs. It is pharmaceutical-grade and does not contain lactate – a molecule that is known to compromise long-term patient outcome. The two Normocarb HF formulations can help limit metabolic disturbances. Normocarb HF provides a single-solution option for the full spectrum of CRRT protocols and durations – even after 48 hours, when higher bicarbonate solutions can lead to metabolic alkalosis.

The choice of hemofiltration solution should correct and not create metabolic disturbances. Normocarb HF does not contain lactate or dextrose and provides a versatile single-solution option for the full spectrum of CRRT protocols and durations.